Status: Not yet recruiting
Study Examining the Safety and Toxicity of Stereotactic Body Radiotherapy (SBRT) Followed by PCX12 Immunotherapy Delivered by Intratumoral Injection for the Treatment of Patients With Locally Advanced Pancreatic Adenocarcinoma (LAPC)
The purpose of this study is to determine whether a new treatment combining radiation therapy with PCX12 is safe and tolerable.
Participants needed: 24
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Haoming (Carl) QiuUpdated: Feb 5, 2026Locations: 1
Eligibility criteria
Patient with pathologically proven diagnosis of adenocarcinoma of the pancreas [+11]
Progression of disease or metastatic disease after first line systemic therapy [+7]